Post-approval studies (Phase 4)Study completedNCT02149758
What this trial is testing
EFFECT OF SELECTIVE COX-2 INHIBITOR (ETORICOXIB) ALONG WITH SCALING AND ROOT PLANING (SRP) ON CLINICAL PARAMETERS AND SALIVARY LEVEL OF SUPEROXIDE DISMUTASE IN CHRONIC GENERALIZED PERIODONTITIS A DOUBLE-BLIND, PLACEBO-CONTROLLED, DOUBLE-MASKED RANDOMIZED CONTROLLED TRIAL (RCT).
Who this might be right for
Cyclooxygenase Two InhibitorsEtoricoxibPeriodontitis+2 more
Tatyasaheb Kore Dental College 40